← Mechanisms of action
MAP2K2
SINGLE PROTEINHomo sapiens
Preferred name: Dual specificity mitogen-activated protein kinase kinase 2 ChEMBL ↗
Linked proteins
Drugs acting on this target (20)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| as-703988 | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| avutometinib (Avmapki fakzynja) | Inhibitor | approved | Small molecule | MAP2K2 inhibitor |
| azd-8330 | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| balamapimod | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| binimetinib (mektovi) | Inhibitor | approved | Small molecule | MAP2K2 inhibitor |
| ci-1040 | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| cobimetinib (cotellic) | Inhibitor | approved | Small molecule | MAP2K2 inhibitor |
| cs3006 | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| felbamate (Felbatol) | Inhibitor | approved | Small molecule | MAP2K2 inhibitor |
| hl-085 | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| mirdametinib (Gomekli) | Inhibitor | approved | Small molecule | MAP2K2 inhibitor |
| pimasertib | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| rec-4881 | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| refametinib | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| ro-4987655 | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| selumetinib (Koselugo) | Inhibitor | approved | Small molecule | MAP2K2 inhibitor |
| shr7390 | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| tak-733 | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |
| trametinib (mekinist) | Inhibitor | approved | Small molecule | MAP2K2 inhibitor |
| zapnometinib | Inhibitor | experimental | Small molecule | MAP2K2 inhibitor |